Why Edgewise Therapeutics Stock Popped This Week
Source: Motley Fool
2025-05-02 19:07:08 ET
On Thursday, an analyst launched coverage of Edgewise Therapeutics (NASDAQ: EWTX) stock, and the market took notice in a good way. On the back of his bullish view of the company, according to data compiled by S&P Global Market Intelligence , its share price vaulted nearly 14% higher across the week.
That professional was Guggenheim's Debjit Chattopadhyay, who initiated his Edgewise Therapeutics coverage with a buy recommendation, and price target of $41 per share. That's well more than double the biotech stock's most recent closing price, just shy of $17.
Image source: Getty Images.
Edgewise Therapeutics Inc.
NASDAQ: EWTX
EWTX Trading
-3.65% G/L:
$37.63 Last:
906,324 Volume:
$40 Open:
EWTX Latest News
June 01, 2026 08:30:00 am
Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
EWTX Stock Data
$3,280,862,770
54,628,112
N/A
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Boulder
